These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34703487)

  • 1. The effect of lycopene on serum level of cardiac biomarkers in patients undergoing elective percutaneous coronary intervention: A randomized controlled clinical trial.
    Asgary S; Soltani R; Daraei F; Salehizadeh L; Vaseghi G; Sarrafzadegan N
    ARYA Atheroscler; 2021 Jan; 17(1):1-7. PubMed ID: 34703487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from procedural myocardial injury by omega-3 polyunsaturated fatty acids (PUFAs): is related with lower levels of creatine kinase-MB (CK-MB) and troponin I?
    Foroughinia F; Salamzadeh J; Namazi MH
    Cardiovasc Ther; 2013 Oct; 31(5):268-73. PubMed ID: 23134549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial.
    Aslanabadi N; Jafaripor I; Sadeghi S; Hamishehkar H; Ghaffari S; Toluey M; Azizi H; Entezari-Maleki T
    J Clin Pharmacol; 2018 Feb; 58(2):144-151. PubMed ID: 28841229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial injury following elective percutaneous coronary intervention.
    Aslanabadi N; Safaie N; Asgharzadeh Y; Houshmand F; Ghaffari S; Garjani A; Dousti S; Hamishehkar H; Entezari-Maleki T
    Cardiovasc Ther; 2016 Aug; 34(4):254-60. PubMed ID: 27214383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
    Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
    Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen phosphorylase isoenzyme BB, creatine kinase isoenzyme MB and troponin I for monitoring patients with percutaneous coronary intervention - a pilot study.
    Skitek M; Kranjec I; Jerin A
    Med Glas (Zenica); 2014 Feb; 11(1):13-8. PubMed ID: 24496335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Effect of Intravenous Calcitriol on the Ischemia-Reperfusion Process and Inflammatory Biomarkers in Patients Following Percutaneous Coronary Intervention (PCI).
    Dastan F; Salamzadeh J; Alipour-Parsa S; Sharif Kashani B; Hashempour MM
    Iran J Pharm Res; 2019; 18(Suppl1):282-290. PubMed ID: 32802107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Pretreatment with Omega-3 Supplement on Cardiac Necrosis Markers in Chronic Kidney Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
    Foroughinia F; Foroozmehr M
    J Res Pharm Pract; 2017; 6(2):94-99. PubMed ID: 28616432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of High-Dose Allopurinol Pretreatment on Cardiac Biomarkers of Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial.
    Alemzadeh-Ansari MJ; Hosseini SK; Talasaz AH; Mohammadi M; Tokaldani ML; Jalali A; Pourhosseini H
    Am J Ther; 2017; 24(6):e723-e729. PubMed ID: 28984632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rosuvastatin dose-loading on serum sLox-1, hs-CRP, and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI).
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Int J Clin Exp Med; 2015; 8(11):21565-71. PubMed ID: 26885106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-blocker use before elective percutaneous coronary intervention as a risk factor for periprocedural myocardial injury incidence in male patients below 75 years old: a single-center retrospective study.
    Wang M; Lv Q; Wang Y; Wang Y; Lin M; Zhao L; Fu G; Zhang W
    Ann Palliat Med; 2021 May; 10(5):5055-5068. PubMed ID: 34044554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
    Garcia-Garcia HM; McFadden EP; von Birgelen C; Rademaker-Havinga T; Spitzer E; Kleiman NS; Cohen DJ; Kennedy KF; Camenzind E; Mauri L; Steg PG; Wijns W; Silber S; van Es GA; Serruys PW; Windecker S; Cutlip D; Vranckx P
    JACC Cardiovasc Interv; 2019 Oct; 12(19):1954-1962. PubMed ID: 31601389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
    Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
    Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin for the prevention of myocardial injury following elective percutaneous coronary intervention; a pilot randomized clinical trial.
    Aslanabadi N; Entezari-Maleki T; Rezaee H; Jafarzadeh HR; Vahedpour R
    Eur J Pharmacol; 2019 Sep; 858():172471. PubMed ID: 31228455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.
    Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF
    Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?
    Nafasi L; Rahmani R; Shafiee A; Salari A; Abdollahi A; Meysamie A
    Curr Med Res Opin; 2014 Mar; 30(3):381-6. PubMed ID: 23952289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Ndrepepa G; Colleran R; Braun S; Xhepa E; Hieber J; Cassese S; Fusaro M; Kufner S; Laugwitz KL; Schunkert H; Kastrati A
    Catheter Cardiovasc Interv; 2018 Feb; 91(2):215-223. PubMed ID: 28500730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.